CABKA (CABKA.AS) Fundamental Analysis & Valuation

AMS:CABKA • NL00150000S7

Current stock price

1.76 EUR
+0.02 (+1.15%)
Last:

This CABKA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CABKA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CABKA has reported negative net income.
  • CABKA had a positive operating cash flow in the past year.
  • CABKA had negative earnings in 4 of the past 5 years.
  • CABKA had a positive operating cash flow in each of the past 5 years.
CABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFCABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.60%, CABKA is doing worse than 81.82% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -23.30%, CABKA is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
ROA -7.6%
ROE -23.3%
ROIC N/A
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
CABKA.AS Yearly ROA, ROE, ROICCABKA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

  • CABKA's Operating Margin has declined in the last couple of years.
  • CABKA's Gross Margin of 45.67% is in line compared to the rest of the industry. CABKA outperforms 54.55% of its industry peers.
  • CABKA's Gross Margin has been stable in the last couple of years.
  • CABKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.67%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
CABKA.AS Yearly Profit, Operating, Gross MarginsCABKA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CABKA.AS Health Analysis

2.1 Basic Checks

  • CABKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CABKA remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CABKA has been increased compared to 5 years ago.
  • CABKA has a worse debt/assets ratio than last year.
CABKA.AS Yearly Shares OutstandingCABKA.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CABKA.AS Yearly Total Debt VS Total AssetsCABKA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • CABKA has an Altman-Z score of 1.05. This is a bad value and indicates that CABKA is not financially healthy and even has some risk of bankruptcy.
  • CABKA has a worse Altman-Z score (1.05) than 63.64% of its industry peers.
  • The Debt to FCF ratio of CABKA is 13.67, which is on the high side as it means it would take CABKA, 13.67 years of fcf income to pay off all of its debts.
  • CABKA's Debt to FCF ratio of 13.67 is in line compared to the rest of the industry. CABKA outperforms 54.55% of its industry peers.
  • CABKA has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.19, CABKA is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 13.67
Altman-Z 1.05
ROIC/WACCN/A
WACC6.25%
CABKA.AS Yearly LT Debt VS Equity VS FCFCABKA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • CABKA has a Current Ratio of 0.68. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CABKA's Current ratio of 0.68 is on the low side compared to the rest of the industry. CABKA is outperformed by 81.82% of its industry peers.
  • CABKA has a Quick Ratio of 0.68. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CABKA has a Quick ratio of 0.37. This is amonst the worse of the industry: CABKA underperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.37
CABKA.AS Yearly Current Assets VS Current LiabilitesCABKA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CABKA.AS Growth Analysis

3.1 Past

  • The earnings per share for CABKA have decreased strongly by -169.23% in the last year.
  • CABKA shows a decrease in Revenue. In the last year, the revenue decreased by -2.64%.
  • CABKA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.52% yearly.
EPS 1Y (TTM)-169.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.07%
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-2.49%

3.2 Future

  • CABKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.05% yearly.
  • CABKA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.15% yearly.
EPS Next Y-266.67%
EPS Next 2Y-6.9%
EPS Next 3Y41.34%
EPS Next 5Y45.05%
Revenue Next Year-1.01%
Revenue Next 2Y2.21%
Revenue Next 3Y3.8%
Revenue Next 5Y5.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CABKA.AS Yearly Revenue VS EstimatesCABKA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
CABKA.AS Yearly EPS VS EstimatesCABKA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

2

4. CABKA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CABKA. In the last year negative earnings were reported.
  • Also next year CABKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CABKA.AS Price Earnings VS Forward Price EarningsCABKA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CABKA is on the same level as its industry peers.
  • CABKA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.02
EV/EBITDA 8.44
CABKA.AS Per share dataCABKA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • CABKA's earnings are expected to grow with 41.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.9%
EPS Next 3Y41.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CABKA.AS Dividend Analysis

5.1 Amount

  • No dividends for CABKA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CABKA.AS Fundamentals: All Metrics, Ratios and Statistics

CABKA

AMS:CABKA (3/23/2026, 7:00:00 PM)

1.76

+0.02 (+1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.63%
Ins Owner ChangeN/A
Market Cap71.63M
Revenue(TTM)180.00M
Net Income(TTM)-12.16M
Analysts85
Price Target3.19 (81.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-30.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF 13.02
P/OCF 3.48
P/B 1.37
P/tB 1.44
EV/EBITDA 8.44
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.14
FCFY7.68%
OCF(TTM)0.51
OCFY28.76%
SpS4.42
BVpS1.28
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.6%
ROE -23.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.67%
FCFM 3.06%
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 13.67
Debt/EBITDA 0.58
Cap/Depr 75.5%
Cap/Sales 8.39%
Interest Coverage N/A
Cash Conversion 120.89%
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.37
Altman-Z 1.05
F-Score4
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)138.03%
Cap/Depr(5y)116.14%
Cap/Sales(3y)12.71%
Cap/Sales(5y)11.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.07%
EPS Next Y-266.67%
EPS Next 2Y-6.9%
EPS Next 3Y41.34%
EPS Next 5Y45.05%
Revenue 1Y (TTM)-2.64%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-2.49%
Revenue Next Year-1.01%
Revenue Next 2Y2.21%
Revenue Next 3Y3.8%
Revenue Next 5Y5.15%
EBIT growth 1Y-968.03%
EBIT growth 3Y-68.28%
EBIT growth 5Y-53%
EBIT Next Year640.01%
EBIT Next 3Y116.79%
EBIT Next 5Y66.92%
FCF growth 1Y274.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.8%
OCF growth 3Y-9.12%
OCF growth 5Y-4.78%

CABKA / CABKA.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CABKA (CABKA.AS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CABKA.AS.


What is the valuation status of CABKA (CABKA.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to CABKA (CABKA.AS). This can be considered as Overvalued.


Can you provide the profitability details for CABKA?

CABKA (CABKA.AS) has a profitability rating of 2 / 10.


What is the expected EPS growth for CABKA (CABKA.AS) stock?

The Earnings per Share (EPS) of CABKA (CABKA.AS) is expected to decline by -266.67% in the next year.


Is the dividend of CABKA sustainable?

The dividend rating of CABKA (CABKA.AS) is 0 / 10 and the dividend payout ratio is -30.51%.